Volume 11, Number 6—June 2005
Dispatch
Methicillin-resistant Staphylococcus aureus in Community-acquired Skin Infections
Gregory J. Moran*†
, Ricky N. Amii*, Fredrick M. Abrahamian*†, and David A. Talan*†
, Ricky N. Amii*, Fredrick M. Abrahamian*†, and David A. Talan*†
Table
Clinical features and epidemiologic characteristics of patients with skin and soft tissue infections*
| Feature/characteristic | MRSA, n = 44 (%) | Other pathogens, n = 52 (%) |
|---|---|---|
| Hospitalized in last year | 6 (14) | 6 (12) |
| Prior, unsuccessful antimicrobial drug treatment | 15 (34) | 15 (29) |
| Injection drug use | 9 (20) | 16 (31) |
| Jail in last year† | 3/36 (8) | 3/48 (6) |
| Homeless | 9 (20) | 10 (19) |
| Abscess present | 41 (93) | 44 (85) |
*MRSA, methicillin-resistant Staphylococcus aureus.
†This information was not available for 8 MRSA patients and 4 patients with other pathogens.
Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.